NanoViricides (NYSE:NNVC) Now Covered by StockNews.com

Equities research analysts at StockNews.com began coverage on shares of NanoViricides (NYSE:NNVC – Get Rating) in a research report issued on Wednesday. The brokerage set a “sell” rating on the stock.

NanoViricides Trading Up 3.7 %

Shares of NYSE:NNVC opened at $1.39 on Wednesday. The company has a 50 day moving average of $1.37 and a 200 day moving average of $1.64. The stock has a market cap of $16.18 million, a P/E ratio of -2.32 and a beta of 1.14. NanoViricides has a 12 month low of $1.04 and a 12 month high of $3.88.

About NanoViricides

(Get Rating)

NanoViricides, Inc is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R.